Discover 130 paid clinical trials in Fort Smith, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 130
Active & Responsive
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
for
Non Small Cell Lung Cancer,
2 locations in Fort Smith
Sponsor: PrECOG, LLC.
Sex: All
Age: 18+
Code: NCT06538038
Recruiting
Active & Responsive
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
for
Colorectal Cancer
1 location in Fort Smith
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT05234177
Recruiting
Active & Responsive
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
for
AAA, AAA - Abdominal Aortic Aneurysm
1 location in Fayetteville
Sponsor: Endologix
Sex: All
Age: 21+
Code: NCT05064540
Recruiting
Active & Responsive
Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence
for
Squamous Cell Carcinoma of Head and Neck
1 location in Fayetteville
Sponsor: University of Arkansas
Sex: All
Age: 18 - 70+
Code: NCT05952934
Phase2, Recruiting
Active & Responsive
A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension
for
Knee Osteoarthritis
1 location in Fayetteville
Sponsor: Canary Medical
Sex: All
Age: 18+
Code: NCT06040827
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Protein and Polycystic Ovary Syndrome (PCOS)
for
Polycystic Ovary Syndrome (PCOS)
1 location in Fayetteville
Sponsor: University of Arkansas, Fayetteville
Sex: Female
Age: 18 - 50
Code: NCT07158723
Recruiting
Active & ResponsiveNew
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
for
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma,
1 location in Fort Smith
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT04566328
Phase3, Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for
Anatomic Stage II Breast Cancer AJCC v8,
1 location in Fort Smith
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06058377
Phase3, Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer